logo
  

TELUS Corp. To Buy LifeWorks For C$2.3 Bln In Cash And Stock

TELUS Corporation (TU), a Canadian national telecom firm, said on Thursday that it has inked a deal to buy LifeWorks, Inc. for C$33 per share, or C$2.3 billion, and the assumption of net debt of approximately C$600 million.

The cash and stock deal, expected to be closed in the final quarter, will allow the acquirer to pay the 50 percent of the total consideration in cash and remainng 50 percent in TELUS' common shares.

Accordingly, the LifeWorks' shareholders will receive either C$33 in cash or 1.06420 share of TELUS for each LifeWorks' share held.

The offer price of C$33 per share implies a premium of 89 percent to the volume weighted average price of the shares of LifeWorks for the 20 trading days ending June 14.

Acquisition adds major scale to TELUS Health having annual revenue of around C$1.6 billion.

The acquisition is also expected to significantly boost TELUS Health's vision of employer-based healthcare, increasing access to high quality, proactive healthcare and mental wellness for employees.

For 2021, LifeWorks posted consolidated revenues and adjusted EBITDA of over C$1 billion and C$195 million, respectively, around 6 per cent of TELUS' consolidated revenue, and 3 percent of adjusted EBITDA, reported for 2021.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration announced the intended availability of base powder to make around 6 million bottles of specialty formula from Mexico as part of its efforts to meet the nationwide supply shortage caused by Abbott Nutrition recall. Reckitt Nutrition/Mead Johnson Nutrition will send an initial shipment of 331 thousand pounds of base powder for PurAmino Hypoallergenic Formula. Shares of Deutsche Telekom AG were gaining more than 1 percent in the morning trading in Germany after the telecom major on Thursday raised its fiscal 2022 earnings outlook again, despite reporting lower profit in its second quarter. Adjusted EBITDA AL, a key earnings metric, increased, while adjusted EBITDA AL margin dropped. Lyons Magnus LLC has expanded its initial recall of nutritional and beverage products to include additional brands and code dates, the U.S. Food and Drug Administration announced. The products were recalled due to the potential for microbial contamination, including from the organisms Cronobacter sakazakii and Clostridium botulinum.
Follow RTT